JENBURKT PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/05/2019 ,inter alia, to consider and approve 1. to approve the audited financial statements for the quarter and financial year ended 31 March,2019.
2. to recommend dividend for the financial year ended 31 March,2019.